Zscaler CapEx increased by 2.6% to $17.76M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 18.2%, from $15.02M to $17.76M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 35.9% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.81M | $13.95M | $6.45M | $13.99M | $27.60M | $21.25M | $25.20M | $18.68M | $26.24M | $27.07M | $28.66M | $30.89M | $35.65M | $49.38M | $17.03M | $15.02M | $72.16M | $60.05M | $17.31M | $17.76M |
| QoQ Change | — | -5.8% | -53.7% | +116.7% | +97.3% | -23.0% | +18.6% | -25.9% | +40.5% | +3.1% | +5.9% | +7.8% | +15.4% | +38.5% | -65.5% | -11.8% | +380.5% | -16.8% | -71.2% | +2.6% |
| YoY Change | — | — | — | — | +86.4% | +52.3% | +290.5% | +33.6% | -4.9% | +27.4% | +13.7% | +65.4% | +35.8% | +82.4% | -40.6% | -51.4% | +102.4% | +21.6% | +1.7% | +18.2% |